MedTrace Logo

Epidemiological Study of the COVID-2019 in Participating Organizations.

NCT05043142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3632

Last updated 2021-10-01

Study results available
· View outcomes & findings →

Summary

Exhaustive, cross-sectional, non-interventional, multicenter retrospective epidemiological study, case study aimed to determine the relationship between the systematic use of prophylactics to prevent SARS, including COVID-2019, and the risks of incidence and serious complications of COVID-2019 among staff of participating organizations.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

ELISA test for the antibodies to COVID-2019.

Each subject will be assigned an individual number, which will be used for conduction of a rapid ELISA test for the antibodies to COVID-2019. Subjects will be notified of the test results.

Sponsors & Collaborators

  • Pharmaxi LLC

    collaborator INDUSTRY

  • Yuria-Pharm

    lead INDUSTRY

Principal Investigators

  • Tetiana Sprynsian · Yuria-Pharm

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-16
Primary Completion
2021-06-23
Completion
2021-06-23

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05043142 on ClinicalTrials.gov